Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An analysis of clinical and geographical metadata of over 75,000 records in the GISAID COVID-19 database

Anjelina Velazquez, Mhealyssah Bustria, Youwen Ouyang, View ORCID ProfileNiema Moshiri
doi: https://doi.org/10.1101/2020.09.22.20199497
Anjelina Velazquez
1Department of Computer Science & Information Systems, California State University San Marcos, San Marcos, CA, 92096, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mhealyssah Bustria
1Department of Computer Science & Information Systems, California State University San Marcos, San Marcos, CA, 92096, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youwen Ouyang
1Department of Computer Science & Information Systems, California State University San Marcos, San Marcos, CA, 92096, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niema Moshiri
2Department of Computer Science & Engineering, UC San Diego, La Jolla, CA, 92093, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niema Moshiri
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

During the SARS-CoV-2 outbreak that caused the coronavirus pandemic it is important now more than ever that scientists and public health officials work side-by-side and use their available resources to track patient information from those that have been affected by the novel coronavirus. The ability to track the disease helps identify possible trends and patterns that can be used by public health officials to make more informed decisions. Tracking data like this may be the key to helping states and countries safely re-open. However, when analyzing large collections of data there is the occurrence of confounding factors such as biases in patient sampling. In this project, a massive collection of COVID-19 data was analyzed, and explored potential biases in patient sampling were explored.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by NSF grant NSF-2028040 to N.M., the Google Cloud Platform (GCP) Research Credits Program, and the UC San Diego Department of Biomedical Informatics (DBMI) Short Term Training Program (STTP).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted using data from a public database (GISAID). No IRB approval is necessary.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All raw data is available on the GISAID database. The Jupyter notebook written to perform the data analysis can be found here: https://colab.research.google.com/drive/12KULPYkIQsxc-v8ayZcIEtf43tOxZfkh?usp=sharing

https://www.gisaid.org/

https://colab.research.google.com/drive/12KULPYkIQsxc-v8ayZcIEtf43tOxZfkh?usp=sharing

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted September 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An analysis of clinical and geographical metadata of over 75,000 records in the GISAID COVID-19 database
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An analysis of clinical and geographical metadata of over 75,000 records in the GISAID COVID-19 database
Anjelina Velazquez, Mhealyssah Bustria, Youwen Ouyang, Niema Moshiri
medRxiv 2020.09.22.20199497; doi: https://doi.org/10.1101/2020.09.22.20199497
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An analysis of clinical and geographical metadata of over 75,000 records in the GISAID COVID-19 database
Anjelina Velazquez, Mhealyssah Bustria, Youwen Ouyang, Niema Moshiri
medRxiv 2020.09.22.20199497; doi: https://doi.org/10.1101/2020.09.22.20199497

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)